An Immunohistochemical and Ultrastructural Study of Pancreatic Microcystic Serous Cyst Adenoma with Special Reference to Tumor-Associated Microvasculature and Vascular Endothelial Growth Factor in Tumor Cells

REFERENCES

• Alpert LC, Truong LD, Bossart MI, Spjut HJ. Microcystic adenoma (serous cystadenoma) of the pancreas. a study of 14 cases with immunohistochemical and electron-microscopic correlation. Am J Surg Pathol. 1988;12:251–263. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Baba M, Hirai S, Kawakami T, , et al. Tumor suppresser protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene. 2001;20:2727–2736. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bardeesy N, Morgan J, Sinha M, , et al. Obligate roles for p16ink4a and p19Arf–p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol. 2002;22:635–643. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bronson RT, Strauss W, Wheeler W. Pancreatic ectasia in uremic macaques. Am J Pathol. 1982;106:342–347. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Robbins SL, Cotran RS, Kumar V. Robbins Pathologic Basis of Disease. ed. 6, Philadelphia: WB. Saunders; 1999.
   Google Scholar
• Dabbs D. Diagnostic Immunohistochemistry. New York: Churchill Livingstone; 2002.
   Google Scholar
• de Paulsen N, Brychzy A, Fournier MC, , et al. Role of transforming growth factor-alpha in von Hippel-Lindau (VHL) − / − clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppresser inactivation and tumorigenesis. Proc Natl Acad Sci USA. 2001;98:1387–1392. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fatyol K, Szalay AA. The p14ARF tumor suppresser protein facilitates nucleolar sequestration of hypoxia-inducible factor 1 alpha (HIF-1 alpha) and inhibits HIF-1-mediated transcription. J Biol Chem. 2001;276:28421–28429. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ghadially F. Ultrastructural Pathology of the Cell and Matrix. Boston: Butterworth-Heinemann; 1997.
   Google Scholar
• Gilbert S. Developmental Biology. Sunderland, MA: Sinauer Associates; 2000.
   Google Scholar
• Hamilton SR, Aaltonen LA. Pathology and Genetics of Tumors of the Digestive System. World Health Organization Classification of Tumors; Lyon, IARC Press; 2000.
   Google Scholar
• Inoue M, Yamazaki K, Shinoda K, , et al. A clinicopathologic case report on macular hole associated with von Hippel-Lindau disease: a novel ultrastructural finding of worm like, wavy tangles of filaments. Graefe's Arch Clin Exp Ophthalmol. 2004;242:881–886. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ivan M, Kaellin WG, Jr. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev. 2001;11:27–34. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Knebelmann B, Ananth S, Cohe HT, Sukhatme VP. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res. 1998;58:226–231. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kosmahl M, Wanger J, Peters K, Sipos B, Kloppel G. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Pathol. 2004;28:339–346. [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Mohr VH, Vortmeyer AO, Zhuang Z. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol. 2000;157:1615–1621. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppresser gene on chromosome 10q. Am J Pathol. 2001;158:317–321. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rampy BA, Waxman I, Xiao S-Y, Logrono R. Serous cyst adenoma of pancreas with papillary features: a diagnostic pitfall on fine-needle aspiration biopsy. Arch Pathol Lab Med. 2001;125:1592–1594. [CSA]
   Web of Science ®Google Scholar
• Ravi R, Mookerjee B, Bhujwalla ZM, , et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha. Genes Dev. 2000;14:34–44. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sharpless NE, DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev. 1999;9:22–30. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Solcia E, Capella C, Kloppel G. Tumors of the pancreas. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1997.
   Google Scholar
• Sternberg S. Histology for Pathologists. Philadelphia: Lippincott-Raven; 1976.
   Google Scholar
• Von Hippel E. Uber eine sehr seltene erkrankung der Netzhaut: Klinische beobachtungen. Graefe's Arch Ophthalmol. 1904;59:83. [CSA], [CROSSREF]
   Google Scholar
• Warshaw AL, Compton CC, Lewanrowski K, Gardenosa G, Mueller PR. Cystic tumors of the pancreas: new clinical, radiologic, and pathologic observations in 67 patients. Ann Surg. 1990;212:432–445. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wieser RJ, Faust D, Diettrich C, Oesch F. pl6lnk4a mediates contact-inhibition of growth. Oncogene. 1999;18:277–281. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yamazaki K. A unique pancreatic ductal adenocarcinoma with carcinosarcomatous histology, immunohistochemical distribution of hCG-beta, and the elevation of serum alpha-feto protein. J Submicrosc Cytol Pathol. 2003;35:343–349. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yamazaki K. Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma: ultrastructural differentiation and immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactant proteins. Virchows Arch. 2004;445:145–153. [CSA]
   Web of Science ®Google Scholar
• Yamazaki K. Electron microscopy and immunohistochemistry studies of pulmonary carcinosarcomas expressing the transcription factor MEF-2 and showing significant cell-to-cell, cell-to-matrix, and epithelial–mesenchymal interactions. Virchows Arch. 2004;444:542–553. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar